semaglutide development Semaglutide: Global Generic Opportunity Ahead semaglutide glp-1 analogue Development of
Description
Extensive regulation of nicotinate phosphoribosyltransferase (NAPRT) expression in human tissues and tumors
As GLP-1 receptor agonists continue to be used in more patients, it is important for clinicians to be aware of the potential benefits of this treatment as well as potential risks, especially as the medical field works to determine how to maintain the weight loss seen with these medications long term
This personalized approach helps ensure patients receive the right compound at the right dose for their unique biology
Lei S, Clydesdale L, Dai A, Cai X, Feng Y, Yang D, et al
Pharmacol Res 186:106550
